<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 20: Steady-State Pharmacokinetics of Atazanavir with Ritonavir in HIV-Infected Pregnant Women in the Fed State</caption>
<col width="39%"></col>
<col width="21%"></col>
<col width="21%"></col>
<col width="19%"></col>
<thead>
<tr>
<th align="center" stylecode="Toprule " valign="top">
<content stylecode="bold"> </content>
</th>
<th align="center" colspan="3" stylecode="Toprule " valign="top">
<content stylecode="bold">Atazanavir 300 mg with ritonavir 100 mg</content>
</th>
</tr>
<tr>
<th align="left" stylecode="Botrule " valign="bottom">
<content stylecode="bold">Pharmacokinetic Parameter</content>
</th>
<th align="center" stylecode="Botrule " valign="top">
<content stylecode="bold">2nd Trimester</content>
<br/>
<content stylecode="bold">(n=5<sup>a</sup>)</content>
</th>
<th align="center" stylecode="Botrule " valign="top">
<content stylecode="bold">3rd Trimester</content>
<br/>
<content stylecode="bold">(n=20)</content>
</th>
<th align="center" stylecode="Botrule " valign="top">
<content stylecode="bold">Postpartum<sup>b</sup>
</content>
<br/>
<content stylecode="bold">(n=34)</content>
</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="4" stylecode="Botrule" valign="top">
<sup>a</sup> Available data during the 2nd trimester are limited.<br/>
<sup>b</sup> Atazanavir peak concentrations and AUCs were found to be approximately 28% to 43% higher during the postpartum period (4-12 weeks) than those observed historically in HIV-infected, non-pregnant patients. Atazanavir plasma trough concentrations were approximately 2.2-fold higher during the postpartum period when compared to those observed historically in HIV-infected, non-pregnant patients.<br/>
<sup>c</sup> C<sub>min</sub> is concentration 24 hours post-dose.</td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="Toprule ">
<paragraph>C<sub>max</sub> ng/mL</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>3078.85</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>3291.46</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph>5721.21</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>   Geometric mean (CV%)</paragraph>
</td>
<td align="center">
<paragraph>(50)</paragraph>
</td>
<td align="center">
<paragraph>(48)</paragraph>
</td>
<td align="center">
<paragraph>(31)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>AUC ng•h/mL</paragraph>
</td>
<td align="center">
<paragraph>27657.1</paragraph>
</td>
<td align="center">
<paragraph>34251.5</paragraph>
</td>
<td align="center">
<paragraph>61990.4</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>   Geometric mean (CV%)</paragraph>
</td>
<td align="center">
<paragraph>(43)</paragraph>
</td>
<td align="center">
<paragraph>(43)</paragraph>
</td>
<td align="center">
<paragraph>(32)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph>C<sub>min</sub> ng/mL<sup>c</sup>
</paragraph>
</td>
<td align="center">
<paragraph>538.70</paragraph>
</td>
<td align="center">
<paragraph>668.48</paragraph>
</td>
<td align="center">
<paragraph>1462.59</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph>   Geometric mean (CV%)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>(46)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>(50)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph>(45)</paragraph>
</td>
</tr>
</tbody>
</table>